Gland Pharma has named Ajay Sahni as the new CEO of its Singapore subsidiary, Gland Singapore, effective November 2, 2026.

Sanofi is set to pursue larger acquisitions and enhance its growth strategy under the leadership of CEO Belen Garijo, aiming ...

Senores Pharmaceuticals has announced its Q2 FY27 financial results, showcasing a 25% increase in revenue to ₹192 crore, ...

Wockhardt reports a 24% increase in Q2 revenue, reaching ₹939 crore, but net profit drops as the company invests heavily in ...

India's pharmaceutical industry has experienced unprecedented double-digit growth over the past four quarters, driven mainly by chronic care drug sales. Expectations of sustainable growth continue as ...

Granules India receives a form 483 from the FDA with 11 observations during inspection, highlighting process and documentation improvements needed at their Gagillapur facility. No data integrity or ...

Laurus Labs expands its capabilities in the oligonucleotide and peptide sectors with strategic acquisitions, enhancing R&D, ...

Fresenius has entered a major development agreement with WuXi Biologics to enhance its biosimilars pipeline, targeting a ...

Mumbai: Bengaluru-based Biocon has secured license to launch its proposed biosimilar of Johnson and Johnson’s blockbuster therapy, Stelara in nine more markets. The latest agreement singed with ...

Beijing: China's drug regulator said on Monday it approved the blood thinner asundexian from Bayer , a potential boost for the German drugmaker in the world's second-largest pharmaceutical market as ...

AstraZeneca reveals a strategic plan to save $1.5 billion annually for investment in its drug pipeline, signaling a ...

A Delhi court discharges former Joint Drugs Controller Dr. S. Eswara Reddy and three others in a bribery case involving ...